SEARCH

SEARCH BY CITATION

References

  • 1
    IDF. Diabetes Atlas. 4th edn. Brussels: International Diabetes Federation, 2009.
  • 2
    IDF Clinical Guidelines Task Force. Global Guideline for Type 2 Diabetes. Brussels: International Diabetes Federation, 2005.
  • 3
    NICE. Type 2 Diabetes. The Management of Type 2 Diabetes. NICE clinical guideline 66. London: National Institute for Health and Clinical Excellence, 2008.
  • 4
    American Diabetes Association. Standards of medical care in diabetes—2010. Diabetes Care 2010; 33: S11S61.
  • 5
    Gray A, Raikou M, McGuire A, Fenn P, Stevens R, Cull C et al. Cost-effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). UK Prospective Diabetes Study Group. Br Med J 2000; 320: 13731378.
  • 6
    Huang ES, Zhang Q, Brown SE, Drum ML, Meltzer DO, Chin MH. The cost-effectiveness of improving diabetes care in US federally qualified community health centers. Health Serv Res 2007; 42: 21742193.
  • 7
    Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008; 359: 15771589.
  • 8
    Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008; 358: 580591.
  • 9
    Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Br Med J 2000; 321: 405412.
  • 10
    UKPDS Research Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 837853.
  • 11
    Zoungas S, de Galan BE, Ninomiya T, Grobbee D, Hamet P, Heller S et al. Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: new results from the ADVANCE trial. Diabetes Care 2009; 32: 20682074.
  • 12
    American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33: S62S69.
  • 13
    Geistanger A, Arends S, Berding C, Hoshino T, Jeppsson JO, Little R et al. Statistical methods for monitoring the relationship between the IFCC reference measurement procedure for hemoglobin A1c and the designated comparison methods in the United States, Japan and Sweden. Clin Chem 2008; 54: 13791385.
  • 14
    Duke SA, Colagiuri S, Colagiuri R. Individual patient education for people with type 2 diabetes mellitus. Cochrane Database Syst Rev 2009; 1: CD005268.
  • 15
    Ellis SE, Speroff T, Dittus RS, Brown A, Pichert JW, Elasy TA. Diabetes patient education: a meta-analysis and meta-regression. Patient Educ Couns 2004; 52: 97105.
  • 16
    Loveman E, Frampton GK, Clegg AJ. The clinical effectiveness of diabetes education models for Type 2 diabetes: a systematic review. Health Technol Assess 2008; 12: 1136.
  • 17
    Peyrot M, Rubin RR, Lauritzen T, Snoek FJ, Matthews DR, Skovlund SE. Psychosocial problems and barriers to improved diabetes management: results of the Cross-National Diabetes Attitudes, Wishes and Needs (DAWN) Study. Diabet Med 2005; 22: 13791385.
  • 18
    Simmons D, Lillis S, Swan J, Haar J. Discordance in perceptions of barriers to diabetes care between patients and primary care and secondary care. Diabetes Care 2007; 30: 490495.
  • 19
    Kraushaar LE, Krämer A. Are we losing the battle against cardiometabolic disease? The case for a paradigm shift in primary prevention. BMC Public Health 2009; 9: 64.
  • 20
    Davies MJ, Heller S, Skinner TC, Campbell MJ, Carey ME, Cradock S et al. Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial. Br Med J 2008; 336: 491495.
  • 21
    Stettler C, Allemann S, Jüni P, Cull CA, Holman RR, Egger M et al. Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: meta-analysis of randomized trials. Am Heart J 2006; 152: 2738.
  • 22
    Kirkman MS, Williams SR, Caffrey HH, Marrero DG. Impact of a program to improve adherence to diabetes guidelines by primary care physicians. Diabetes Care 2002; 25: 19461951.
  • 23
    Tabrizi JS, O’Rourke PK, Wilson AJ, Coyne ET. Service quality for Type 2 diabetes in Australia: the patient perspective. Diabet Med 2008; 25: 612617.
  • 24
    Guldberg TL, Lauritzen T, Kristensen JK, Vedsted P. The effect of feedback to general practitioners on quality of care for people with type 2 diabetes. A systematic review of the literature. BMC Fam Pract 2009; 10: 30.
  • 25
    Duran A, Runkle I, Matia P, de Miguel MP, Garrido S, Cervera E et al. Family physician and endocrinologist coordination as the basis for diabetes care in clinical practice. BMC Endocr Disord 2008; 8: 9.
  • 26
    Grant RW, Meigs JB. Prevalence and treatment of low HDL cholesterol among primary care patients with type 2 diabetes: an unmet challenge for cardiovascular risk reduction. Diabetes Care 2007; 30: 479484.
  • 27
    The Diabetes and Nutrition Study Group of the Spanish Diabetes Association (GSEDNu). Diabetes Nutrition and Complications Trial: adherence to the ADA nutritional recommendations, targets of metabolic control, and onset of diabetes complications. A 7-year, prospective, population-based, observational multi-center study. J Diabetes Complications 2006; 20: 361366.
  • 28
    The Diabetes and Nutrition Study Group of the Spanish Diabetes Association (GSEDNu). Diabetes Nutrition and Complications Trial (DNCT). Diet and risk of microangiopathy progression: the role of polyunsaturated fatty acids and monounsaturated fatty acids consumption. Obes Metab 2006; 2: 612.
  • 29
    da Silva R, Bach-Faig A, Raidó Quintana B, Buckland G, Vaz de Almeida MD, Serra-Majem L. Worldwide variation of adherence to the Mediterranean diet, in 1961–1965 and 2000–2003. Public Health Nutr 2009; 12: 16761684.